Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
about
Update on surgical treatment of pancreatic neuroendocrine neoplasmsNear-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapyBilocal recurrence of a neuroendocrine carcinoma of the small intestine: A case report.Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CTResults of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.Schmorl Nodes Can Cause Increased 68Ga DOTATATE Activity on PET/CT, Mimicking Metastasis in Patients With Neuroendocrine Malignancy.Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary SitesTargeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemiaThe value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.Continued rapid growth in (68) Ga applications: update 2013 to June 2014.Hybrid PET/MR imaging: physics and technical considerations.Small Bowel Neuroendocrine Tumors with Inguinal Metastases: A Diagnostic and Therapeutic Dilemma.The role of multimodal treatment in patients with advanced lung neuroendocrine tumors.
P2860
Q26864361-9DBEFD74-A42B-4349-86DD-5BFB3ACCCEB2Q33825897-B2A839DA-E393-4DE6-9AFE-9457B2F34400Q34768375-AE727CDE-A7DA-4C2D-9D90-DFFC1ABDE4DFQ34987701-675C3C4D-C765-418C-90F2-25B7811BDCADQ35483867-0D3C6B2E-7C55-4F8B-A0B5-FE6E4A76670CQ35695753-9C37A497-06F9-44E6-9BAC-6B5ED27B02BCQ35891227-A4130668-3906-437A-A816-5B7AC501350AQ35894770-8B7C7B03-DB33-4C96-833D-0DAD00D9F48EQ36540526-DBF974DB-8025-4530-9A60-EDE0BFAB7817Q36914468-0F5E174D-4A12-4485-91E8-A8872E596942Q37140477-7F093B81-CF1E-4495-8589-F8BC5CF01A7CQ38241845-A9B186ED-570B-4800-87CA-47889774D839Q38358666-33BA609C-5E73-4030-ACD4-C7306FE8C94DQ38488830-4F3AD33F-8EA5-45BA-AF6F-63DC33F5CCC4Q41840203-706FED10-91E0-4D9F-ADDC-E78D54D0F724Q45896572-631D594D-9E9E-4D62-BDDA-76A6C30AE5B7
P2860
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
@en
type
label
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
@en
prefLabel
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
@en
P2093
P356
P1433
P1476
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
@en
P2093
Björn Wängler
Christine Spitzweg
Christoph J Auernhammer
Christopher Uebleis
Gerwin P Schmidt
Marcus Hacker
Martin Reincke
Peter Bartenstein
Ramona Cindea-Drimus
P304
P356
10.1148/RADIOL.13122501
P407
P577
2013-10-28T00:00:00Z